Valuation: Cochlear Limited

Market Cap 9.3B 6.54B 5.86B 5.41B 4.89B 9.15B 623B 64.52B 25.74B 326B 24.56B 24.04B 1,033B P/E 2027 *
31.6x
P/E 2028 * 25.1x
Enterprise Value 9.07B 6.38B 5.72B 5.27B 4.77B 8.92B 608B 62.92B 25.1B 318B 23.95B 23.44B 1,007B EV / Sales 2027 *
3.83x
EV / Sales 2028 * 3.6x
Free-Float
99.42%
Yield 2027 *
2.53%
Yield 2028 * 2.8%
1 day+1.01%
1 week+2.17%
Current month+2.90%
1 month-0.50%
3 months+17.26%
6 months+59.60%
Current year-44.89%
1 week 137.98
Extreme 137.98
146
1 month 124.33
Extreme 124.33
146.81
Current year 88.74
Extreme 88.74
278.35
1 year 88.74
Extreme 88.74
291.2
3 years 88.74
Extreme 88.74
350.31
5 years 88.74
Extreme 88.74
350.31
10 years 88.74
Extreme 88.74
350.31
Manager TitleAgeSince
Chief Executive Officer - 03/01/2018
Director of Finance/CFO - 01/01/2025
Chief Tech/Sci/R&D Officer - 01/07/2019
Director TitleAgeSince
Chairman 58 21/08/2021
Director/Board Member - 14/11/2017
Director/Board Member 69 13/12/2016
Date Insider Type Main position Quantity % Market Cap. Importance
9/1/26 A Buy

Director

1,100 0.0017%
8/24/26 A Buy

Director

444 0.0007%
8/24/26 A Buy

Director

257 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
+1.01%+2.17%-50.43%-40.77% 6.54B
+1.43%+1.98%-15.18%+13.71% 181B
-5.24%-4.29%-20.33%+11.95% 120B
-0.06%+1.66%+6.62%+38.62% 119B
+3.40%+1.66%-42.35%+9.46% 91.44B
+1.03%+0.84%-2.18%+80.02% 63.07B
-0.46%-0.64%+9.87%+80.82% 55.8B
-0.15%-0.36%+10.48%-21.07% 54.03B
-2.29%+0.49%-10.41%+42.06% 45.38B
+0.48%+2.07%-1.00%-6.36% 34.37B
Average -0.11%+0.54%-11.49%+20.84% 77B
Weighted average by Cap. -0.17%+0.76%-10.55%+24.94%

Financials

2027 *2028 *
Net sales 2.37B 1.67B 1.49B 1.38B 1.25B 2.33B 159B 16.43B 6.56B 83.06B 6.25B 6.12B 263B 2.5B 1.76B 1.58B 1.45B 1.32B 2.46B 168B 17.34B 6.92B 87.68B 6.6B 6.46B 278B
Net income 292M 206M 184M 170M 154M 287M 19.58B 2.03B 809M 10.25B 771M 755M 32.45B 369M 260M 233M 215M 194M 364M 24.76B 2.56B 1.02B 12.96B 976M 955M 41.04B
Net Debt -231M -163M -146M -134M -122M -227M -15.48B -1.6B -639M -8.1B -610M -597M -25.65B -313M -220M -197M -182M -165M -308M -20.96B -2.17B -866M -10.97B -826M -808M -34.74B
Projected Income Statement - Annual - Cochlear Limited
Logo Cochlear Limited
Cochlear Limited provides implantable hearing solutions and a range of implants and sound processor upgrades. Its segments include Cochlear Implants, Services and Acoustics. The Cochlear Implants segment offers Cochlear implant systems. The Services segment offers sound processor upgrades, accessories and other. The Acoustics segment offers bone conduction systems and sound processor upgrades. Its products and services portfolio include Cochlear implant portfolio, Acoustic solutions portfolio, Recipient support tools, and Cochlear Connected Care solutions. Its Cochlear Connected Care solutions include Cochlear Nucleus SmartNav System, Cochlear Custom Sound Pro Fitting Software, Cochlear Link, Cochlear Remote Assist, and Cochlear Remote Check. Cochlear implant portfolio includes Cochlear Nucleus System. Acoustic solutions portfolio includes Cochlear Osia System, and Cochlear Baha System. Recipient support tools include Cochlear Nucleus, Baha and Osia Smart Apps and Cochlear CoPilot App.
Employees
5,400
Date Price Change Volume
30/10/26 A$143.64 +1.01% 312,231
29/10/26 A$142.20 +1.57% 403,599
28/10/26 A$140.00 +0.13% 536,229
27/10/26 A$139.82 -1.41% 578,661
26/10/26 A$141.82 -3.40% 446,725
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - Cochlear Limited
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
16
Last Close Price
142.20AUD
Average target price
136.34AUD
Spread / Average Target
-4.12%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Cochlear Limited